Eversept Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Eversept Partners’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-205,815	Closed	-$23.8M	–	73
2023 Q3	$23.8M	Sell	205,815 -269,495	-57%	-$29M	2.01%	13
2023 Q2	$48.9M	Sell	475,310 -343,814	-42%	-$36.3M	4.09%	7
2023 Q1	$89.4M	Sell	819,124 -245,322	-23%	-$27.1M	6.23%	5
2022 Q4	$121M	Sell	1,064,446 -205,145	-16%	-$17M	10.61%	2
2022 Q3	$78.6M	Buy	1,269,591 +380,008	+43%	+$26.6M	6.81%	4
2022 Q2	$71M	Buy	889,583 +279,644	+46%	+$26.5M	5.04%	5
2022 Q1	$64.2M	Sell	609,939 -223,811	-27%	-$21.8M	4.93%	5
2021 Q4	$89.8M	Buy	833,750 +199,080	+31%	+$21.7M	5.74%	2
2021 Q3	$69.5M	Sell	634,670 -32,068	-5%	-$3.33M	4.81%	4
2021 Q2	$62.4M	Sell	666,738 -28,721	-4%	-$2.64M	4.16%	6
2021 Q1	$64M	Buy	695,459 +164,483	+31%	+$13.9M	3.32%	7
2020 Q4	$38.8M	Sell	530,976 -76,781	-13%	-$5.71M	4.56%	6
2020 Q3	$47.2M	Sell	607,757 -346,981	-36%	-$23.9M	10.49%	1
2020 Q2	$53.1M	Buy	+954,738	New	+$40.8M	7.28%	2

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Eversept Partners's HZNP Position: Q4 2023 in Review

Eversept Partners sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 205,815 shares — an estimated $23.8M sold.

Eversept Partners first reported a position in HZNP in Q2 2020 and held it in 14 quarters. The position peaked at $121M in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Eversept Partners reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Eversept Partners sold 205,815 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $23.8M.
Eversept Partners first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2020 and held it in 14 quarters.
Eversept Partners's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $121M in Q4 2022.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Eversept Partners's 13F filing for Q4 2023, filed 14 Feb 2024.